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Substrates of the N-end rule pathway include proteins with de-
stabilizing N-terminal residues. These residues are recognized by
E3 ubiquitin ligases called N-recognins. Ubr1 is the N-recognin of
the yeast Saccharomyces cerevisiae. Extracellular amino acids or
short peptides up-regulate the peptide transporter gene PTR2,
thereby increasing the capacity of a cell to import peptides. Cup9
is a transcriptional repressor that down-regulates PTR2. The induc-
tion of PTR2 by peptides or amino acids involves accelerated
degradation of Cup9 by the N-end rule pathway. We report here
that the Ubr1 N-recognin, which conditionally targets Cup9 for
degradation, is phosphorylated in vivo at multiple sites, including
Ser300 and Tyr277. We also show that the type-I casein kinases Yck1
and Yck2 phosphorylate Ubr1 on Ser300, and thereby make possible
(‘‘prime’’) the subsequent (presumably sequential) phosphoryla-
tions of Ubr1 on Ser296, Ser292, Thr288, and Tyr277 by Mck1, a kinase
of the glycogen synthase kinase 3 (Gsk3) family. Phosphorylation
of Ubr1 on Tyr277 by Mck1 is a previously undescribed example of
a cascade-based tyrosine phosphorylation by a Gsk3-type kinase
outside of autophosphorylation. We show that the Yck1/Yck2-
mediated phosphorylation of Ubr1 on Ser300 plays a major role in
the control of peptide import by the N-end rule pathway. In
contrast to phosphorylation on Ser300, the subsequent (primed)
phosphorylations, including the one on Tyr277, have at most minor
effects on the known properties of Ubr1, including regulation of
peptide import. Thus, a biological role of the rest of Ubr1 phos-
phorylation cascade remains to be identified.
Mck1  proteolysis  Yck1
The uptake of di- and tripeptides (di/tripeptides) in the yeastSaccharomyces cerevisiae is regulated by the N-end rule
pathway, one proteolytic pathway of the Ub-proteasome system
(Fig. 1A) (1–4). The N-end rule relates the in vivo half-life of a
protein to the identity of its N-terminal residue (5–8). Degra-
dation signals (degrons) that are targeted by the N-end rule
pathway include a set called N-degrons (5, 9). The main deter-
minant of an N-degron is a destabilizing N-terminal residue of
a substrate protein (5, 9).
The N-end rule has a hierarchic structure that involves the
primary, secondary, and tertiary destabilizing N-terminal resi-
dues (Fig. 1A). Destabilizing activities of these residues differ by
their requirements for a preliminary enzymatic modification, a
set of reactions that includes N-terminal deamidation and argi-
nylation (8–12). In mammals and other multicellular eukaryotes,
the set of arginylated residues contains not only Asp and Glu but
also N-terminal Cys, which is arginylated after its oxidation to
Cys-sulfinate or Cys-sulfonate. The in vivo oxidation of N-
terminal Cys requires nitric oxide (NO), oxygen (O2), and/or
their derivatives (Fig. 1A) (8, 11).
E3 Ub ligases of the N-end rule pathway are called N-recognins
(5, 8, 13, 14). They bind to primary destabilizing N-terminal
residues.At least 4N-recognins, includingUbr1,mediate theN-end
rule pathway in mammals and other multicellular eukaryotes (8).
N-recognins share a70-residuemotif called theUBR box.Mouse
Ubr1 and Ubr2 are the sequelogous (15) 200-kDa RING-type E3
Ub ligases. The N-end rule pathway of S. cerevisiae is mediated by
a singleN-recognin,Ubr1, a 225-kDa sequelog ofmammalianUbr1
and Ubr2 (Fig. 1A) (2, 13, 14). Ubr1 contains at least 3 substrate-
binding sites. The type-1 and type-2 sites are specific for basic (Arg,
Lys, His) and bulky hydrophobic (Trp, Phe, Tyr, Leu) N-terminal
residues, respectively. The third binding site of Ubr1 recognizes, in
particular, an internal (non-N-degron) degradation signal in Cup9,
a transcriptional repressor of a regulon that includes PTR2, which
encodes the transporter of di/tripeptides (16). This site of Ubr1 is
autoinhibited but can be activated through the binding of di/
tripeptides to the type-1/2 sites of Ubr1 (1, 2, 13). The resulting
acceleration of theUbr1-dependent degradation of Cup9 decreases
its levels and thereby induces the Ptr2 transporter. This positive-
feedback circuit allows S. cerevisiae to detect the presence of
extracellular peptides and to react by increasing their uptake (1, 2).
The functions of the N-end rule pathway include the sensing of
NO, oxygen, short peptides, and heme (Fig. 1A); the maintenance
of high fidelity of chromosome segregation, through the degrada-
tion of a separase-produced fragment of cohesin subunit; regulation
of peptide import, through the degradation of Cup9 (see above);
regulation of signaling by transmembrane receptors, through the
NO/O2-dependent degradation of specificRGSproteins that down-
regulate G proteins; regulation of apoptosis, meiosis, spermato-
genesis, neurogenesis, and cardiovascular development in mam-
mals, and regulation of leaf senescence in plants (refs. 1, 2, 4, 8,
10–12, 17 and refs. therein). Mutations in human Ubr1 are the
cause of Johansson–Blizzard Syndrome (JBS), which includes men-
tal retardation, physicalmalformations and severe pancreatitis (18).
In the present study, we show that the Ubr1 Ub ligase is
phosphorylated in vivo atmultiple sites, including Ser300 and Tyr277.
We found that the type-I casein kinases Yck1 and Yck2 phosphor-
ylate Ubr1 on Ser300 and thereby make possible (‘‘prime’’) the
subsequent phosphorylation of Ubr1 on Ser296, Ser292, Thr288, and
Tyr277. The latter phosphorylations are mediated by Mck1, a
member of the glycogen synthase kinase 3 (Gsk3) family. We also
show that phosphorylation of Ubr1 on Ser300 plays a major role in
the control of peptide import by the N-end rule pathway.
Results and Discussion
Identification of in Vivo Ubr1 Phosphorylation Sites Using Mass
Spectrometry. To determine the sites of Ubr1 phosphorylation,
we used tryptic digestion of Ubr1, capillary liquid chromatog-
raphy, and peptide sequencing by mass spectrometry (cLC-MS/
MS) [supporting information (SI) Text and Fig. S1]. The follow-
ing Ubr1-derived phosphopeptides were identified: (i)
pY277ENDYMFDGTTTAK and YENDYMFDGTTpT288AK,
(ii)pT291SPSNpS296PEASPLAKorTpS292PSNpS296PEASPLAK,
(iii) pT291SPSNpS296PEApS300PLAK or TpS292PSNpS296-
PEApS300PLAK, (iv) EHEpS1196EFDEQDNDVDMVGEK, (v)
NLDEDDpS1938DDNDDDER, and (vi) NLDEDDpS1938-
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DDNDDpS1944DER. Although cLC-MS/MS alone could not
distinguish between phosphorylation at Thr291 vs. Ser292, the
latter residue was the more likely one, given the presence of a
consensus phosphorylation site for a Gsk3-type kinase (S/T-X-
X-X-S/T). We changed Ser292 of Ubr1 to Ala and found this
mutation (S292A) abolished phosphorylation on Tyr277. To-
gether, these analyses identified 8 in vivo phosphorylation sites
(Fig. 1B). Five of these sites were clustered in a 25-residue region
of the 1,950-residue Ubr1, between the previously delineated
locations (13) of its type-1 and -2 substrate-binding sites (Fig. 1B
and Fig. S1).
In Vivo Phosphorylation of Ubr1 on Tyr277.As a part of this study, we
produced an affinity-purified rabbit antibody (termed
Ab1ScUbr1(1–1140)) to N-terminal half of S. cerevisiae Ubr1. To
detect the in vivo phosphorylation of Tyr277 by a method other
than MS, we also produced an affinity-purified rabbit antibody
(termed Ab1pY277Ubr1) against a peptide that contained phos-
pho-Tyr277 and adjacent Ubr1 sequences. Ab1pY277Ubr1 recog-
nized both the phosphopeptide and Tyr277-phosphorylated Ubr1
(Ubr1pY277) and did not recognize the unphosphorylated peptide
or Ubr1Y277F, which contained a nonphosphorylatable (Phe)
residue at position 277 (Fig. 2 A and B). The epitope(s)
recognized by Ab1pY277Ubr1 could be removed by treating Ubr1
with lambda protein phosphatase; the epitope was retained in
the presence of phosphatase inhibitors (Fig. 2C).
The in vivo levels of Ubr1pY277 (relative to total Ubr1) were
increased upon the addition of glucose, an amino acid such as Trp,
or a type-1 dipeptide such as Arg-Ala (Fig. 2 F–H). We also
expressed Ubr1 in S. cerevisiae CHY50, a [ubr1 pdr5] strain that
was sensitive to a proteasome inhibitor such as MG132. The levels
of Ubr1pY277 were not increased by treatment with MG132 (Fig.
2D). This test was performed in part because some Ubr1 mutants
at position 277, such as Ubr1Y277A, and Ubr1Y277E, were found to
be short-lived in vivo (Fig. S2D andE). These results indicated that
that the identity of a residue at position 277 is critical for a
metabolically stable conformation of Ubr1. The above Ubr1 mu-
tants are described solely in SI (Fig. S2 B–E), because the levels of
Ubr1pY277 were not altered by inhibition of the proteasome (Fig.
2D), suggesting (but not proving) that the metabolic stability of
Ubr1pY277 is comparable to that of Ubr1 unphosphorylated on
Tyr277.
Truncated derivatives of Ubr1 (2, 13) and the Ab1pY277Ubr1
antibody were used to determine ‘‘large-scale’’ requirements for the
in vivo phosphorylation of Ubr1 on Tyr277. Remarkably, no phos-
phorylation on Tyr277 was observed with the fUbr11–717 fragment,
in contrast to ‘‘wild-type’’ levels of Tyr277 phosphorylation with
Ubr11–1140f, fUbr11–1367, fUbr11–1700, and fUbr11–1818 fragments (Fig.
S3A). Thus, a region between positions 717 and 1,140 (Fig. 1B) was
essential for the phosphorylation of Ubr1 on the far-upstream
Tyr277 residue (Fig. S3A), suggesting that this phosphorylation may
require an appropriate conformation and/or a preceding phosphor-
ylation at other residues of Ubr1.
Tyr277 of Ubr1 Is Phosphorylated by Mck1, a Member of the Gsk3
Kinase Family. We used Ab1pY277Ubr1 (Fig. 2 A–C) and a library of
yeast mutants in 27 putative Tyr kinases (see SI Text) to screen for
the ability of thesemutants to phosphorylateUbr1 onTyr277 in vivo.
Amutant lacking theMck1 kinase was found to be nearly incapable
of phosphorylating Ubr1 on Tyr277 (Fig. S4A, lane 5). This defect
could be rescued by wild-type Mck1 but could not be rescued by
Mck1D164A (19), a catalytically inactive mutant (Fig. S4B). Expres-
sion of Mck1Y199F, a possibly leaky mutant in the activation loop of
this kinase (ref. 19 and refs. therein), weakly but detectably rescued
the Tyr277-specific phosphorylation of Ubr1 (Fig. S4B).
Mck1 is a member of the Gsk3 family of kinases, present in all
eukaryotes (19, 20). In addition to Mck1, the S. cerevisiae genome
encodes 3 other kinases of this family, Rim11, Mrk1, and Ygk3. In
contrast to the near absence of Tyr277-specific phosphorylation of
Ubr1 inmck1 cells, this phosphorylation remained unperturbed in
rim11, mrk1, or ygk3 cells (Fig. S4A). Moreover, double and
triple mutants, the latter lacking all 3 Gsk3-type kinases other than
Mck1, did not exhibit a significant decrease in the Tyr277-specific
Ubr1 phosphorylation (data not shown), indicating a unique role of
Mck1 in phosphorylating Ubr1 on Tyr277. We also overexpressed
His6-tagged derivatives of either wild-type Mck1 or its catalytically
inactiveMck1D164Amutant in S. cerevisiae and purified them to near
homogeneity (Fig. S3B). Wild-type Ubr1 and Ubr1Y277F were
expressed in the mck1 strain (Fig. S4A, lane 5) and also purified.
Ubr1 or Ubr1Y277F were incubated with Mck1 or Mck1D164A and
[32]ATP, followed by SDS/PAGEand autoradiography.Wild-type
Mck1 phosphorylated wild-type Ubr1, whereas the amounts of 32P
Fig. 1. The N-end rule pathway, in vivo phosphorylation sites in S. cerevisiae
Ubr1, and the primed cascade of Ubr1 phosphorylation. (A) The S. cerevisiae
N-end rule pathway. N-terminal residues are indicated by single-letter abbrevi-
ations foraminoacids.Yellowovalsdenote the restofaprotein substrate.Hemin
(Fe3-heme) inhibits arginylationbyR-transferase in both S. cerevisiae andmam-
mals (12). MetAPs, methionine aminopeptidases. Reactions in the shaded rect-
angle are a part of the N-end rule pathway that is active in eukaryotes which
produceNO(11). These reactionsmayalsoberelevant toS. cerevisiae,which lacks
NO synthase but can produce NO by other routes, and can also be influenced by
NO from extracellular sources. C* denotes oxidized Cys, either Cys-sulfinate or
Cys-sulfonate (11). Type-1 and -2 destabilizing N-terminal residues of N-end rule
substrates are recognized byUbr1, the sole E3Ub ligase of S. cerevisiae. Through
its third substrate-binding site,Ubr1 targets internal (non-N-terminal) degrons in
substrates (denoted by a larger oval) such as Cup9, a transcriptional repressor (1,
3, 4). (B) Phosphorylated residues of S. cerevisiae Ubr1 identified in the present
work.Also indicatedare theconservedUbr1 regions suchas theUBRbox, theBRR
(basic residues-rich) domain, the Cys/His-rich RING domain, and the UAIN (UBR
autoinhibitory) domain (2). (C) The cascade of Ubr1 phosphorylation discovered
in the present work. Initial phosphorylation of Ubr1 on Ser300 by the CKI-type
Yck1/Yck2kinasesmakespossible (‘‘primes’’) thesubsequent (apparently sequen-
tial) phosphorylations of Ubr1 by Mck1 (a Gsk3-type kinase) on Ser296, Ser292,
Thr288, and Tyr277. Also indicated is the identified function of Ser300
phosphorylation.
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were much lower (but not zero; see below) with Ubr1Y277F, which
could not be phosphorylated at position 277 (Fig. 3A). Immuno-
blotting of the same reaction products with Ab1pY277Ubr1 directly
confirmed thatMck1 phosphorylatedUbr1 on Tyr277 (Fig. 3A).We
conclude that Mck1 is by far the major (possibly the sole) kinase
that phosphorylates Ubr1 on Tyr277.
Reciprocal coimmunoprecipitation tests confirmed that Ubr1
specifically interacted with Mck1 (Fig. 3 B and C). As would be
expected, the apparent affinity of Mck1 for Ubr1 was higher with
either unphosphorylated Ubr1 (isolated frommck1 cells express-
ing catalytically inactive Mck1D164A-ha) or with Ubr1Y277F (which
could not be phosphorylated at position 277) than with wild-type
Ubr1 from cells containing wild-type Mck1 (Fig. 3C). The binding
of the Ubr1 Ub ligase to Mck1 did not make the latter short-lived
in vivo (data not shown).
A ‘‘Primed’’ Ubr1 Phosphorylation Cascade That Begins at Ser300
Involves 3 Other Serines/Threonines and Concludes with Tyr277. We
identified Thr288, Ser292, Ser296, and Ser300 of Ubr1 as the sites of its
in vivo phosphorylation downstream of Tyr277, a residue phosphor-
ylated byMck1 (Figs. 1B and 3A andFig. S1). ANetPhosKprogram
(www.cbs.dtu.dk/services/NetPhosK) pinpointed Thr288, Ser292,
Ser296, and Ser300 of Ubr1 as putative sites of phosphorylation by
Fig. 2. Phosphorylation of Ubr1 on Tyr277. (A) Characterization of antibody,
termed Ab1pY277Ubr1, that was raised against a Ubr1 phosphopeptide
QFLNDLKpY277ENDY. Dot immunoblotting with affinity-purified Ab1pY277Ubr1,
using indicated amounts of the spotted QFLNDLKpYENDY phosphopeptide and
its unphosphorylated counterpart. (B) Specificity of Ab1pY277Ubr1. Purified wild-
type Ubr1 (which contains Ubr1pY277) and Ubr1Y277F were subjected to SDS-
NuPAGE (4–12%) and immunoblotted with affinity-purified Ab1pY277Ubr1
(1:1,000), and thereafter with Ab1ScUbr1(1–1140). (C) Purified wild-type Ubr1 (0.25
g) was incubated with 400 units of  phosphatase (-PPase) in the presence or
absence of phosphatase inhibitors for 2 h at 30 °C, followed by SDS/PAGE and
sequential immunoblotting, as in B. (D) S. cerevisiae CHY50 [ubr1 pdr5] ex-
pressing the N-terminally flag-tagged Ubr1 (fUbr1), was grown in SC(-Leu) and
treated for 3 h eitherwithMG132 (at 50M) orwith an equivalent volume of its
stock-solution solvent dimethyl sulfoxide. Cell extracts were subjected to SDS/
PAGEandsequential immunoblotting,as inB. (E)Ubr1phosphorylationonTyr277
depends on phosphorylation at other sites. JD55 (ubr1) cells were transformed
with pFlagUBR1SBX-based plasmids that expressed wild-type Ubr1 or its indi-
cated derivatives. Cells were grown to A600 of1 in SC(-Leu). Cell extracts were
subjected to SDS-NuPAGE (4–12%) and sequential immunoblotting, as in B. (F
andG)Wild-type LRB906 [YCK1 YCK2] or LRB756 [yck1 yck2ts] strains (Table S1)
that expressed wild-type fUbr1 or fUbr1S300A (in the ubr1 background) were
grown inagalactose-containingmedium,withorwithouta subsequentaddition
of glucose, either at 25 °C (permissive temperature for Yck2ts) or at 30 °C (semi-
permissive temperature forYck2ts). Cell extractswere subjected toSDS/PAGEand
sequential immunoblotting with Ab1pY277Ubr1 and anti-flag antibodies. (H)
AVY26 (ubr1) S. cerevisiae expressing wild-type Ubr1 from pSOB33 (Tables S1
and S2) was grown to A600 of0.8 in SHMmedium in the presence of indicated
dipeptides,at1mMor10mM,or inthepresenceofTrp(98M).Cellextractswere
subjected to SDS/PAGE and immunoblotting, as in B. (I) CHY201 (ubr1) S.
cerevisiae (Table S1) carried the plasmid pSS4 (PPTR2-lacZ) and either pCH100
(wild-type Ubr1) or pCH159 (Ubr1MR1), the latter expressing Ubr1C1220S, which is
inactive as an E3 (14). Cultures were grown at 25 °C in galactose-containing
SGal(-Ura,-Leu) medium to A600 of 0.8, followed by the addition of either
galactose (to 4% total) (white bars) or glucose (to 4%) (black bars), further
incubation for 2.5 h, and measurements of gal activity in cell extracts.
Fig. 3. Phosphorylation of Ubr1 by Yck1/Yck2 and Mck1 kinases. (A) Purified
Mck1phosphorylatesUbr1onTyr277.Wild-type fUbr1and its fUbr1Y277Fderivative
were purified from mck1 S. cerevisiae; 0.1 g of fUbr1 or fUbr1Y277F were
incubated with 0.1 g of either partially purified (‘‘Ni-NTA’’) or additionally
purified (‘‘Mono-S’’) ha-tagged Mck1, or with its indicated derivatives in the
presence of -[32]ATP at 30 °C for 30 min, followed by SDS/PAGE and sequential
immunoblottingwithAb1pY277Ubr1, anti-flag, and anti-ha antibodies. (B) Extracts
fromJD55(ubr1) cellsexpressing fUbr1andMck1-hawere incubatedwithbeads
only (lane2)oranti-flagbeads (lane3).Boundproteinswereelutedandanalyzed
by SDS/PAGEand immunoblottingwithanti-HAandanti-flagantibodies. Lane1,
0.1% of total extract. (C) Extracts from JD55 (ubr1) cells expressing fUbr1 or
fUbr1Y277F and coexpressing Mck1-ha were processed for immunoprecipitation,
SDS/PAGE, and immunoblotting, as inB. ‘‘Input’’ samples before immunoprecipi-
tation, with immunoblotting using anti-flag. Lane 1, cells expressed fUbr1 alone
(control). Lane2, sameas lane1but cells expressedboth fUbr1andMck1-ha. Lane
3, CHY89 (mck1 ubr1) cells that lacked endogenousMck1 and expressed both
fUbr1 and Mck1D164A-ha. Lane 4, same as lane 2 but with cells that expressed
fUbr1Y277F andMck1-ha. (D) CHY201 (ubr1) and CHY202 (ubr1 yck1 yck2ts) S.
cerevisiae carriedpSS4 (PPTR2-lacZ) andeitherpCH100 (wild-typeUbr1)orpCH114
(Ubr1S300A) (Tables S1 and S2). Cultureswere grown in SGal(-Ura,-Leu) at 25 °C to
A600 of 0.8, and thereafter were shifted to 37 °C for 20 min, followed by the
addition of either galactose (to 4% total) (white bars) or glucose (to 4%) (filled
bars) and further incubationat37 °C for2.5h, followedbymeasurementsofgal
activity in cell extracts. (E) CHY203 (ubr1) and CHY204 (ubr1 yck1 yck2ts) S.
cerevisiae carriedpSS4 (PPTR2-lacZ) andeitherpCH100 (wild-typeUbr1)orpCH114
(Ubr1S300A) (Tables S1 and S2). Cultures were grown to A600 of 0.8 in SHM
medium (see SI Text) at 25 °C and thereafterwere shifted to 37 °C for 2.5 h in the
samemedium either without or with the addition of Trp to 98 M, followed by
processing as in D.
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Gsk3-type kinases. To address these issues, we constructed Ubr1
mutants that retained Tyr277 but contained single or multiple
mutations to Ala at the above Ser/Thr sites. We then used
Ab1pY277Ubr1, which recognized Ubr1pY277, to determine the extent
of in vivo phosphorylation of mutant Ubr1 proteins on Tyr277.
Strikingly, no phosphorylation on Tyr277 was observed with
Ubr1T288A, Ubr1S292A, and Ubr1S296A, and also with multisite
mutants Ubr1S296A,S300A, Ubr1S292A,S296A,S300A, and
Ubr1T288A,S292A,S296A,S300A, whereas Ubr1S300A exhibited a detect-
able but greatly reduced phosphorylation on Tyr277 (Fig. 2E). Thus,
the Mck1-mediated phosphorylation on Tyr277 is the last step of a
phosphorylation cascade that involves the obligatory preceding
(‘‘priming’’) phosphorylations of Ser/Thr residues that are close to
position 277 of Ubr1 (Fig. 1 B and C). These data, together with a
low but significant in vitro Mck1-mediated phosphorylation of
Ubr1Y277F, which could not be phosphorylated at position 277 (Fig.
3A), strongly suggested (but did not formally prove) that the
observed phosphorylation of Ubr1 on Thr288, Ser292, and Ser296 is
also carried out by Mck1 (Fig. 1C).
Yck1 and Yck2 Are ‘‘Priming’’ Kinases That Phosphorylate Ubr1 on
Ser300 and Initiate the Mck1-Mediated Phosphorylations on Thr288,
Ser292, Ser296, and Tyr277. In a cascade that is referred to as ‘‘primed’’
phosphorylation, specific residues of a protein must be phosphor-
ylated sequentially rather than independently of one another, in
that a ‘‘downstream’’ phosphorylation event requires one or more
of preceding phosphorylations (21). Kinases that phosphorylate at
a position required for subsequent phosphorylations are referred to
as ‘‘priming’’ kinases (refs. 20–22 and refs. therein). In the known
Gsk3 cascades, a frequently encountered preference is for a prior
phosphorylation, often by a distinct kinase, of a residue at 4
position relative to a residue to be phosphorylated next. This
previously established rule is consistent with the distances between
the Ser300, Ser296 Ser292, and Thr288 residues of Ubr1 (Fig. 1C). A
prior phosphorylation by a priming kinase is not always strictly
essential, in that in most cases a priming phosphorylation greatly
increases the activity of a Gsk3-type kinase at a ‘‘dependent’’
phosphorylation site, typically by 100- to 1,000-fold (21).
According to the NetPhosK program, Ser300 of S. cerevisiaeUbr1
was a plausible phosphorylation site for either Gsk3-type kinases or
Pho85, of the CDK kinase family. We found that null mutations in
either S. cerevisiae Pho85 or the non-Mck1 kinases of the Gsk3
family (Rim11, Mrk1, and Ygk3) did not affect theMck1-mediated
phosphorylation of Ubr1 on Tyr277 in vivo (Fig. S4A). Previous
work has shown that Yck1/Yck2, 2 sequelogous S. cerevisiae kinases
of the casein kinase-I (CKI) family (23) are essential components
of systems such as glucose-mediated signaling pathways (24), bud-
localized mRNA translation (25), and the signaling mediated by
extracellular amino acids, particularly the SPS pathway (26–28). In
mammals, CKI-type kinases regulate a multitude of processes,
including the cell cycle, circadian rhythms, membrane trafficking,
chromosome segregation, and apoptosis (23).
S. cerevisiae contains 4 sequelogous kinases of the CKI family:
Yck1, Yck2, Yck3, and Hrr25. Yck1 and Yck2 are peripheral
membrane proteins whose localization at the plasma membrane
requires palmitylation of their C-terminal Cys-Cys motif (refs. 27
and 28 and refs. therein). Yck1 and Yck2 complement each other
in a number of functions (27). We carried out coimmunoprecipi-
tation with the flag-tagged Ubr1 (fUbr1) and myc-tagged Yck1
(Yck1-myc) that were coexpressed in ubr1 cells. fUbr1 was coim-
munoprecipitated with Yck1-myc (Fig. S4 C and D). Moreover,
fUbr1 could be efficiently phosphorylated, in the presence of
[32]ATP, in immunoprecipitates with wild-type (C-terminally
tagged) Yck1-myc but not with inactive Yck1K98R-myc or with
beads alone (Fig. S4E). Yck1 assays were also carried with GST-
Ubr1227–327 and GST-Ubr1227–327,S300A. GST-Ubr1227–327 was phos-
phorylated in immunoprecipitates with wild-typeYck1-myc but not
with inactive Yck1K98R-myc (Fig. S4F). Crucially, the otherwise
identical GST-Ubr1227–327,S300A, which contained Ala at position
300 of Ubr1, was at most weakly phosphorylated by Yck1-myc (Fig.
S4F). Together, these results indicated that the CKI-type Yck1 and
Yck2 kinases (either one of them was sufficient; data not shown)
functioned as priming kinases of Ubr1, phosphorylating its Ser300
and thereby making possible (‘‘priming’’) the cascade of Mck1-
mediated phosphorylations that converged on Tyr277 (Fig. 1C).
Yck1/Yck2-Primed, Mck1-Mediated Phosphorylation of Ubr1 on Tyr277
Is Increased by Glucose, Amino Acids, or Type-1 Dipeptides. The
addition of glucose, an amino acid such as Trp, or a type-1 dipeptide
such as Arg-Ala to a growth medium significantly increased the in
vivo levels of Ubr1pY277 (Fig. 2 F–H). To determine whether
glucose-mediated increases of Ubr1pY277 required the priming
Yck1/Yck2 kinases that initially phosphorylate Ubr1 on Ser300, we
used a wild-type [YCK1 YCK2] strain and a temperature-sensitive
(ts) [yck1 yck2ts] strain that lacked Yck1 and contained a ts-Yck2
kinase (Yck2ts). These strains (Table S1) were constructed to
express either wild-type Ubr1 or Ubr1S300A, which could not be
phosphorylated at position 300. Exponential cultures in a 2%
galactose-containing medium at 25 °C (permissive temperature for
Yck2ts) or at 30 °C (semipermissive temperature) were left growing
with galactose or were modified by the addition of glucose to 4%
and further incubation for 2.5 h at either 25 °Cor 30 °C.With [YCK1
YCK2] cells, phosphorylation ofUbr1 on Tyr277 was increased upon
the addition of glucose at 25 °C. By contrast, at 30 °C the level of
Ubr1pY277 was greatly reduced in [yck1 yck2ts] cells (Fig. 2 F and
G). In addition, glucose did not increase phosphorylation of Ubr1
on Tyr277 in [yck1 yck2ts] cells when these cells were cultured
further at the nonpermissive temperature of 37 °C for 2.5 h (data
not shown). The increased phosphorylation on Tyr277 required
Ser300, because no change in the levels of Ubr1pY277 was observed
in otherwise identical experiments with Ubr1S300A (Fig. 2 F andG).
In agreement with this result, the level of Ubr1pY277 increased upon
the addition of glucose at 25 °C but not at 30 °C in [yck1 yck2ts]
cells (Fig. 2 F and G).
Normal Induction of the Ptr2 Peptide Transporter by Amino Acids,
Dipeptides, or Glucose Requires Phosphorylation of Ubr1 on Ser300 by
Yck1/Yck2. By measuring the expression of PPTR2-lacZ transcrip-
tional reporter, we found that the addition of glucose to cells
growing on galactose led to a modest (1.6-fold) but reproducible
induction of the transporter-encoding PTR2 gene in wild-type
(UBR1) cells but not in cells that expressed the catalytically inactive
Ubr1C1220S mutant (Fig. 2I). Glucose-mediated increase of PTR2
expression required the Yck1/Yck2 kinases and phosphorylation of
Ubr1 on Ser300, because no induction of PTR2 by glucose occurred
at 37 °C either in [yck1 yck2ts] cells that expressed wild-type Ubr1
or in [YCK1 YCK2] cells that expressed Ubr1S300A (Fig. 3D).
Addition of an amino acid such as Trp significantly increased the
levels of Ubr1pY277 (Fig. 2H, lane 8; compare with lane 1 or 3). In
vitro kinase assays (data not shown) indicated this effect of Trp was
not mediated by an increase in the activity of the Mck1 kinase. The
addition of Trp also induced the expression of PTR2 by 2-fold
(Fig. 3E). The induction of PTR2 by Trp was nearly abolished in
[YCK1 YCK2] cells that expressed Ubr1S300A instead of wild-type
Ubr1 or in [yck1 yck2ts] cells at 37 °C in the presence of wild-type
Ubr1 (Fig. 3E). Together, these findings strongly suggested that Trp
causes the formation of Ubr1pY277 through the demonstrated (ref.
27 and refs. therein) activation of theYck1/Yck2 kinases by the SPS
pathway or through inhibition of a phosphatase(s) that dephospho-
rylates the phospho-Ser300 residue of Ubr1.
Ubr1S300A was indistinguishable from wild-type Ubr1 in medi-
ating the in vivo degradation of a type-1 N-end rule substrate such
as Arg-gal (Fig. 4A). However, Ubr1S300A was considerably im-
paired in mediating the degradation of either a type-2 N-end rule
substrate such as Tyr-gal (Fig. 4A) or the Cup9 repressor (Fig.
S4G and data not shown). Cup9 is targeted by Ubr1 through an
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internal degron (see Introduction). A strongly impaired ability of
Ubr1S300A to induce PTR2 could also be observed in experiments
where a mixture of amino acids was present (Fig. 4C). The
(previously described) Trp-induced acceleration of Cup9 degrada-
tion (4) was found to be nearly absent in cells that expressed
Ubr1S300A instead ofwild-typeUbr1 (Fig. S4G and data not shown).
This result accounted, at least in part, for the decreased ability of
Ubr1S300A to mediate the induction of PTR2 by amino acids (Figs.
3E and 4C).
Type-1 dipeptides such as Lys-Ala (which bind to Ubr1 and
thereby accelerate Cup9 degradation) can up-regulate peptide
import and thus enable survival of cells on media with peptides as
sole sources of a required amino acid (1). In agreement with other
data (see above) about functional significance of Ubr1 phosphor-
ylation on Ser300, Ubr1S300A was strongly impaired in the growth-
based peptide import assay, in contrast to wild-typeUbr1 (Fig. 4D).
A different test involved Ubr1S300D, in which Ser300 was converted
to Asp, a ‘‘mimic’’ of phospho-Ser. This experiment provided yet
another, independent evidence for the functional importance of
phosphorylation on Ser300. Specifically, the Ubr1S300D mutant was
more active than wild-type Ubr1 (and much more active than
Ubr1S300A) inmediating the expression of PTR2 (Fig. 4C).Whereas
a type-1 dipeptide such asArg-Ala (at 1mM) significantly increased
the levels of Ubr1pY277, a type-2 dipeptide such as Phe-Ala did not
have this effect even at 10 mM (Fig. 2H), for reasons that remain
to be understood.
Concluding Remarks
Several E3 Ub ligases of the Ub-proteasome system have been
shown to be regulated through phosphorylation (refs. 29–31 and
refs. therein). We discovered a ‘‘primed’’ phosphorylation cascade
that involves Ser300, Ser296, Ser292, Thr288, and Tyr277 of Ubr1, the
E3Ub ligase (N-recognin) of theN-end rule pathway in S. cerevisiae
(Figs. 1B andC and 5). This cascade ismediated byYck1 andYck2,
2 sequelogous type-I casein kinases that act as ‘‘priming’’ kinases for
the Mck1 kinase of the Gsk3 family. Phosphorylation of Ubr1 on
Ser300 by the functionally overlappingYck1/Yck2 kinasesmakes the
resulting Ubr1pS300 a substrate of Mck1, which phosphorylates 3
Ser/Thr residues of Ubr1 and completes the cascade by phosphor-
ylating Tyr277 (Fig. 1 B and C). The Tyr277 residue of Ubr1 is an
example of a tyrosine phosphorylation by Mck1, outside of its
autophosphorylation activity. We also showed that the initial
(priming) phosphorylation ofUbr1 onSer300 (Fig. 1C) plays amajor
role in the control of import of di/tripeptides by the N-end rule
pathway (Figs. 1C and 5).
Phosphorylation of Ubr1 on Tyr277 is up-regulated by an extra-
cellular amino acid such as Trp (Fig. 2H). Trp induces the Ptr2
transporter and thereby up-regulates the import of di/tripeptides
(32). The mechanism of Ptr2 induction by Trp was recently found
to involve acceleration of the Ubr1-dependent degradation of the
Cup9 repressor (4). This acceleration requires the amino acid-
sensing SPS (Ssy1-Ptr3-Ssy5) pathway (26, 28, 33). Ssy1, the plasma
membrane-embedded amino acid sensor, transduces its interaction
with an extracellular amino acid such as Trp into a changed
phosphorylation state of Ptr3, an Ssy1-associated protein that
functions downstreamof Ssy1. TheTrp-induced phosphorylation of
Ptr3 ismediated by the Ssy1-dependent activation of theYck1/Yck2
kinases (27, 28). Remarkably, the same kinases were found to
phosphorylate Ubr1 on Ser300, thereby priming the rest of Ubr1
phosphorylation cascade (Figs. 1B andC and 5). Thus, the addition
of Trp up-regulates the cascade phosphorylation of Ubr1 through
the same Ssy1-mediated activation of the Yck1/Yck2 kinases that
Fig. 4. Functional consequences of Ubr1 alterations at
position300. (A)Relative levelsofArg-gal (filledbars)and
Tyr-gal (white bars), a type-1 and a type-2 N-end rule
substrate, respectively (Fig. 1A), inubr1 S. cerevisiaeor in
the same strain that expressed either wild-type Ubr1 or
Ubr1S300A.(B)SameasinAbutanindependentexperiment,
andUbr1Y277F instead ofUbr1S300A. (C) Effects of Ubr1mu-
tations at position 300 on PTR2 expression. S. cerevisiae
JD55 (ubr1) carried pSS4 (PPTR2-lacZ) and either pCH100
(wild-type Ubr1), pCH114 (Ubr1S300A) pCH246 (Ubr1S300D).
CulturesweregrowntoA600of0.8at30 °C inSCcontain-
ing a mixture of compounds (including amino acids) re-
quired by a strain, followed by measurements of gal ac-
tivity in cell extracts. (D) JD55 (ubr1) S. cerevisiae carrying
either the empty vector (pRS315), or pCH100 (wild-type
Ubr1),orpCH114(Ubr1S300A)(TableS2)wereseriallydiluted
5-fold and spotted on SC(-Leu, -Lys) plates containing 110
MLys,or66MLys-Ala,or66MAla-Lys.Theplateswere
incubated at 30 °C for 3 days.
Fig. 5. Summaryofmainfindings. (A)ThecascadeofUbr1phosphorylation.See
Fig.1C foranotherdiagramofthis cascade. (B)TheYck1/Yck2kinasesmediatethe
activityof theaminoacid-sensingSPSpathwayandtheglucose-sensingSnf3/Rgt2
pathway.WefoundthatYck1/Yck2alsofunctionas ‘‘priming’’kinases intheUbr1
phosphorylation cascade (A and Fig. 1C) that involves the Yck1/Yck2 and Mck1
kinases. Stp1 and Stp2 are latent transcription factors, activated through cleav-
ages by Ssy5, that up-regulate, in particular, the expression of the peptide
transporter genePTR2, in aprocess counteractedby theCup9 repressor (28).Also
shown is the characterized positive-feedback circuit (1, 2) that involves the
binding of di/tripeptides with type-1 or -2 destabilizing N-terminal residues (Fig.
1A) to the types-1/2 binding sites of Ubr1, and the resulting allosteric activation
of the third binding site of Ubr1 that targets Cup9 for ubiquitylation. This
activation, which accelerates Cup9 degradation and thereby up-regulates PTR2,
was foundtorequirephosphorylationofUbr1onSer300by theYck1/Yck2kinases.
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also leads to phosphorylation of Ptr3, a component of the SPS
pathway (27, 28, 33).
The impaired ability of Ubr1S300A to increase the rate of Cup9
degradation in response to amino acids or type-1 dipeptides can
account, at least in part, for the demonstrated impairment of
Ubr1S300A in the induction of PTR2 by these effectors (Figs. 3E and
4C; Fig. S4G). In summary, the induction of PTR2 by Trp, a process
that involves the SPS pathway and the Ubr1-dependent accelera-
tion of Cup9 degradation (4), requires phosphorylation of Ubr1 on
Ser300 by the Yck1/Yck2 kinases. These kinases also play a role in
the signaling by glucose in yeast (24), in agreement with the
Yck1/Yck2-dependent up-regulation of Ubr1 phosphorylation on
Tyr277 by glucose, an effect that is not observedwithUbr1S300A (Fig.
2 F and G). In contrast to the Yck1/Yck2-mediated phosphoryla-
tion of Ubr1 on Ser300 that affects both the activity of Ubr1 and the
control of peptide import by the N-end rule pathway, the other
(primed) phosphorylations of Ubr1 (Fig. 1C) appear to have at
most minor effects on the knownUbr1 functions. Thus, a biological
role of the post-Ser300 part of Ubr1 phosphorylation cascade (Fig.
1C) remains to be identified. We also found that mutational
replacements of Tyr277 by either Ala or Glu (the latter a mimic of
phospho-Tyr at this position) converted Ubr1 into a short-lived
protein in vivo (Fig. S2 B–E). Surprisingly, a proteasome-inhibitor
test with Ubr1pY277 (wild-type Ubr1 phosphorylated on Tyr277)
suggested its metabolic stability (Fig. 2D), in contrast to a short in
vivo half-life of, for example, Ubr1Y277E (Fig. S2 B–E). It remains
to be determined definitively whether the phosphorylation of Ubr1
on Tyr277 can lead to its accelerated degradation in vivo.
Although S. cerevisiae Ubr1 is sequelogous to the mammalian
Ubr1/Ubr2 N-recognins (8), the latter lack a sequence that
resembles the Tyr277-containing region of S. cerevisiae Ubr1.
Nevertheless, a counterpart of the functionally critical Ser300
residue of yeast Ubr1 (Fig. 1C) may well be present in mam-
malian Ubr1/Ubr2, which have several potential sites of phos-
phorylation by a CKI-type kinase. In other words, the main
discovery of the present work (Figs. 1C and 5) suggests that
phosphorylation will be found to regulate N-recognins of mul-
ticellular eukaryotes as well.
Methods Summary
For descriptions of materials and methods, including S. cerevisiae
strains, plasmids and PCR primers, see SI Text, and Tables S1–S3.
Standard techniques, including PCR, were used to construct spe-
cific strains and plasmids, including plasmids that encoded Ubr1
mutants. Epitope-tagged Mck1, Ubr1 and their mutant derivatives
or GST fusions to Ubr1 fragments were overexpressed in S.
cerevisiae or Escherichia coli and purified through steps that in-
cluded affinity chromatography. Sites of in vivo phosphoryla-
tion of Ubr1 in S. cerevisiae were mapped using trypsin-
produced fragments of isolated Ubr1 and mass spectrometry
(MS). Ab1ScUbr1(1–1140), an antibody that recognized all species
of S. cerevisiae Ubr1 and Ab1pY277Ubr1, an antibody to a
phosphopeptide that encompassed phospho-Tyr277, were pro-
duced in rabbits. All procedures, including the making and
characterization of antibodies, the immunoblotting and coim-
munoprecipitation assays, pulse–chase assays, and in vitro
kinase assays are described in SI Text.
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